Bone marrow-derived mesenchymal stem cells (BM-MSCs) provide a large quantitative alternative source for regenerative medicine. This study was undertaken to determine the effect of BM-MSCs in the treatment of busulfan-induced azoospermia in guinea pigs. BM-MSCs were isolated from the femur bones of 6 adult guinea pigs as the donor group, and characterized by morphology, MSC markers and osteogenic and adipogenic differentiation. A dose of 40 mg/kg of busulfan was administered at a 21 day interval to induce azoospermia in 6 guinea pigs. Thirty-five days after the second injection of busulfan, transplantation of 1×10 6 BM-MSCs was performed into the seminiferous tubules of the left testes. The right testis was considered as the positive busulfan treated control. The testes of the donor group were applied as an intact normal control. Then, 60 days after cell therapy, histopathological and histomorphometric evaluations of the testes were performed. The seminiferous tubules treated with BM-MSCs, similar to the intact group, showed a normal appearance of spermatogenesis in comparison to the busulfan-induced azoospermic testes. In conclusion, BM-MSCs were effective in the treatment of azoospermia in a guinea pig model where they restore the fertility of busulfaninduced azoospermic animals after transplantation of BM-MSCs. Therefore, this report could open a window in future to the possibility of BM-MSCs transplantation in the treatment of azoospermia in humans, but more studies should be undertaken for further verification.
Introduction
M. Hajihoseini et al.: Azoospermia stem cell therapy wave in guinea pigs (RODRÍGUEZ-CASURIAGA et al., 2011) . Although the seminiferous tubules of guinea pigs are highly enriched in meiotic cells as compared with mice and rats, there has been no study to evaluate the effects of stem cell therapy on the model of guinea pig azoospermia. Therefore, this study was performed to use busulfan for induction of azoospermia and BM-MSCs for cell therapy in this model.
Materials and methods
Animals. Twelve male outbred Dunkin-Hartley guinea pigs (black and brown coat color), weighing 500-550 g, were purchased and kept in polypropylene cages in the Laboratory Animal Center, Shiraz University of Medical Sciences. They were maintained at a controlled temperature (20-22 °C) and a period of 12h lightness/darkness (7.00-19.00 lightning) with free access to food and water. All animal procedures were approved by the Ethical Committee of Shiraz University of Medical Sciences. The guinea pigs were divided into two groups: azoospermic-induced and control (n = 6). The control group was used as cell donors and also their left testis was used as a negative control. In the azoospermic group, the left testis of the azoospermia-induced guinea pigs were treated with BM-MSC and their right testis served as a positive control.
Isolation of BM-MSCs. BM-MSCs were isolated from the femurs of euthanized guinea pigs. Both ends of the bone were cut and the BM was flushed out using a 10 mL syringe filled with Dulbecco's modified eagle medium (DMEM; Biovet, Bulgaria) and 1% penicillin streptomycin (Sigma, USA). After extraction, bone marrow was transferred on ice to the laboratory, under sterile conditions, and BM-MSCs culture and isolation were performed according to the method of ASADI-YOUSEFABAD et al. (2015) . Briefly, bone marrow was diluted with an equal volume of DMEM and centrifuged at 1200 rpm for 7 min. The precipitate was plated in 75 cm 2 flasks containing DMEM, supplemented with 10% fetal bovine serum (FBS; Biovet, Bulgaria), 1% penicillin and streptomycin and 1% l-glutamine (Sigma, USA), and transferred into a CO 2 incubator at 37 °C with 5% CO 2 and saturated humidity. The medium was changed after 24 h and then every 72 h, to remove the non-adherent cells. Adherent cells were subcultured when they were 80% confluent by washing twice with phosphate buffer saline (PBS, Gibco, USA) and using 0.25% trypsin (Gibco, USA) for 3-4 min. To inactivate enzyme activity, the same volume of supplemented DMEM media was added. Cell passage continued until passage 3.
Freezing and thawing of BM-MSCs. To coordinate between azoospermia model preparation and cell isolation and characterization, it was necessary to cryopreserve the isolated cells for further steps of the research. For this purpose, in passage 3 the confluent flasks of BM-MSCs were treated with 0.25% trypsin (Gibco, USA) for 3-4 min and then the enzyme was inactivated by equal amounts of supplemented DMEM media. The cell suspension was centrifuged at 1500 rpm for 5 min, the supernatant removed and the precipitate was suspended in a mixture of 50% DMEM media, 40% FBS, and 10% dimethyl sulfoxide (DMSO; MP Bio), at a density of 2×10 6 viable cells/ml, and was aliquoted into sterile plastic labeled cryovials. They were frozen at -20 °C for one hour and then at -70 °C for 24 h, and finally transferred to liquid nitrogen for long-term storage. Whenever BM-MSCs were needed, they were taken out for thawing and culturing. To thaw the cells, the cryovials were removed from the liquid nitrogen and placed in a 37 °C water bath. Then, cell culture DMEM medium was added and the mixture was centrifuged at 1500 rpm for 5 min. The precipitated cells were plated into a culture flask and transferred into an incubator with 5% CO 2 and saturated humidity at 37 °C. The cells were subcultured once after thawing.
BM-MSCs characterization. For confirmation of the mesenchymal characters of MSCs, the isolated and subcultured cells were evaluated for morphology, cell surface markers and potential of differentiation into osteoblast and chondrocyte cell lines, according to ALIBORZI et al. (2016) . Using an inverted microscope (Olympus, USA), the morphology of the BM-MSCs cells in different passages was determined.
Expressions of markers for MSCs by reverse transcriptase polymerase chain reaction (RT-PCR) were performed. Briefly, BM-MSCs of passage 3 were used to collect total RNA by a column RNA isolation kit (Denazist-Asia, Iran), according to the manufacturer's protocol. Spectrophotometry was undertaken to assess the concentration of the total RNA. AccuPower ® CycleScript RT PreMix (Bioneer, Korea) was used to synthesize the complementary DNAs (cDNAs) according to RNA strains as a template and the kit's instructions. For each reaction, 15 µL of total RNA was used to reach a volume up to 20 µL with the diethylpyrocarbonate-treated water (DEPC-water). Twelve thermal cycles were conducted as follows: 30 sec at 20 °C for primer annealing, 4 min at 42 °C for cDNA synthesis, 30 sec at 55 °C for melting secondary structure and cDNA synthesis, and 5 min at 95 °C for inactivation. Then, 1 µL of template (cDNA) was mixed with other reagents including PCR buffer, taq DNA polymerase, H 2 O, MgCl 2 , dNTPs, and forward and reverse primers of CD34, CD44 and CD90 (Table 1) . Microtubes with 20 µL of the mixture were placed in the Thermocycler (Eppendorf, Germany). Thirty amplification cycles were undertaken as follows: initial denaturation at 95 °C for 5 min followed by 30 cycles of denaturation at 95 °C for 30 sec; annealing at 64 °C, 62 °C, and 61 °C for 30 sec, respectively and extension at 72 °C for 30 sec; and a final polymerization at 72 °C for 5 min. PCR products were subsequently assessed using 1.5% agarose gel electrophoresis next to an appropriate DNA size marker, then stained by power load, visualized under UV light and photographed. In order to compare the differentiation potential of BM-MSCs, cells of passage 3 were used, and osteogenic and adipogenic differentiation induced. For osteogenic and adipogenic differentiation, BM-MSCs were seeded in 6-well plates. After the cells reached 70% confluency, they were cultured for 3 weeks in osteogenic or adipogenic medium. The osteogenic medium contained low glucose DMEM supplement with 100 nM dexamethasone (Sigma-Aldrich), 0.05 mM ascorbate-2-phosphate (Wako Chemicals, Richmond, VA, USA), 10 mM b-glycerophosphate (Sigma-Aldrich), 1% antibiotic/ antimycotic and 10% FBS. Adipogenic medium contained DMEM low glucose, 10% FBS, 0.5 mM isobutyl-methylxanthine (Sigma-Aldrich), 10% FBS, 1 μM dexamethasone, 10 μM insulin, 200 μM indomethacin (Sigma-Aldrich). The medium was replaced every 3 days. On day 21, the cells were fixed by 10% formalin solution (Sigma-Aldrich) for 10 minutes. To detect calcified extracellular matrix and osteogenic differentiation, the cells were stained using Alizarin Red (Sigma-Aldrich) and subsequently washed twice with distilled water. Adipogenic differentiation was detected by Oil Red O (Sigma-Aldrich), which specifically stains lipid droplets.
Induction of azoospermia. Busulfan is a chemotherapeutic drug mostly used in cancer patients (BARTELINK et al., 2014) that has been shown to be responsible for impairment of spermatogenesis (PANAHI et al., 2014) . This study used busulfan for induction of azoospermia. Guinea pigs were intraperitoneally injected with 40 mg/kg of busulfan (Busilvex ® , Pierre Fabre Medicament, Boulogne, France) in 2 doses with a 21 day interval to disrupt spermatogenesis.
Transplantation of BM-MSCs. Thirty-five days after the second busulfan injection, the animals were anesthetized using ketamine (40 mg/kg, Woerden, Netherlands) and xylazine (0.5 mg/kg Alfazyne ® , 2%, Woerden, Netherlands). They were placed in dorsal recumbency, and the abdominal area was prepared for further surgery. One cm incision was performed at the abdominal midline to reach the peritoneal cavity. Under a Zeiss OPMI operating microscope (Carl Zeiss Meditec, Jena, Germany), the fat pad attached to the left seminiferous and testis was pulled gently by an iris forceps until the testis was taken out and clearly visible. A pulled glass pipette was connected to the tube. For injection of BM-MSCs into testis, it was marked by addition of sterile trypan blue (1:1, v/v), which served to monitor the success of the injection, loaded into polyethylene tubing attached to a 1 mL syringe. The cell suspension was gently pushed into the pipette by pressing the syringe. The seminiferous tubules were identified using a stereomicroscope, while 100 µL of BM-MSCs' mixture (10 6 cells) was injected into the lumen of the seminiferous tubules of the busulfan-treated testis (Figs. 1C and 1D ). The testis was returned to the abdominal cavity, and the abdominal wall and skin were sutured. The right testis was considered as the control.
Histopathologic and histomorphometric assessment. The duration of spermatogenesis in guinea pigs is approximately 34 days, with four cycles of 8.5 days (NOLLER et al., 1977) . It has also been shown that the first spermatogenic wave lasts between 40 and 45 days in guinea pigs (RODRÍGUEZ-CASURIAGA et al., 2011) . Therefore, 60 days (approximately 7 expected cycles) after cell transplantation, the animals were euthanized, and both testes were removed and transferred into 10% formalin buffer solution. After fixation, they were embedded in paraffin, and histopathologic sections were made from each block. Five vertical sections from the polar and the equatorial regions of 5 µm thickness were hematoxylin-eosin stained and examined under a light microscope for any spermatogenic activity.
All tubules were evaluated for the presence of any spermatogonia, spermatocytes, and spermatids. Ten identical circular transverse sections were performed in the tubules, each in a different area of the testis, using a systematic random protocol, to assess the stereological indices (PANAHI et al. 2014) . The mean seminiferous tubule diameter (d) was determined by taking the average of two diameters, D 1 and D 2 , at right angles. The crosssectional area (A c ) of the seminiferous tubules was determined using the equation: A c = πD 2 /4, where π is equal to 3.142 and D is the mean diameter of the seminiferous tubules (PANAHI et al., 2014) .
A testis was rated for its spermatogenic potential by a modified spermatogenic index on a scale of 0 to 6 (PANAHI et al., 2014) . The index was based on the appearance of the spermatogenic cells throughout the testis, and included the number of cell layers, types of cells, and the presence of late spermatids in the seminiferous tubules (PANAHI et al., 2014) . The index and criteria were as follows: 0, no spermatogenic cells; 1, only spermatogonia present; 2, spermatogonia and spermatocytes present; 3, spermatogonia, spermatocytes and round (early) spermatids present with <50 late spermatids per tubule; 4, spermatogonia, spermatocytes, and round spermatids present, and up to 50-100 late spermatids per tubule; 5, spermatogonia, spermatocytes, and round spermatids present, and up to 100-150 late spermatids per tubule; and 6, all cell types present and >150 late spermatids per tubule.
Statistical analysis. The data were analyzed using SPSS software (version 18, Chicago, IL, USA). One way ANOVA, followed by LSD post-hoc tests were used for statistical analyses. The spermatogenesis index of seminiferous tubules was compared using the Mann-Whitney U test. P<0.05 was considered significant.
Results

BM-MSCs characterization.
BM-MSCs were adhered to plastic culture flasks and exhibited spindle-shaped morphology. They did not change through all passages (Fig.  1) . The isolated BM-MSCs expressed CD44 and CD90 for MSC markers, but not CD34 for hematopoietic cell markers (Fig. 2) . After 21 days, BM-MSCs in osteogenic and adipogenic induction media differentiated into osteoblasts and adipocytes, respectively. They revealed calcium deposits by Alizarin Red staining, or cytoplasmic lipid droplets with Oil Red O staining (Fig. 3) . Histopathologic findings. After induction of azoospermia in the guinea pigs with a double injection of 10 mg/kg of busulfan, the testes of the positive control guinea pigs were microscopically examined for any spontaneous spermatogenesis recovery, and no sign was observed. After the treatment with busulfan, the seminiferous tubules of the testes not treated with BM-MSCs were empty and their spermatogenesis process was disrupted (Fig. 4A) . The examination of sections showed only Sertoli cell appearance in the samples without BM-MSCs therapy. Histopathological examination of testes in the busulfan treatment group after 60 days revealed some degenerative changes such as seminiferous tubular atrophy and germinal epithelium degeneration in most of the tubules. A large vacuolated lumen occupied the seminiferous tubules and atrophic germinal epithelium covered the peripheral zone of the seminiferous tubules as a thin band (Fig. 4B) . Moreover, there were no spermatozoa in the epididymis of the busulfan treated, azoospermic group. However, the presence was observed of spermatogonia in the seminiferous tubules with BM-MSCs transplantation (Fig. 4C) . Moreover, the tubules appeared to be filled up with germinal cells (spermatogonia, primary spermatocytes, spermatids and sperms) in the sections of the BM-MSCs-treated testes (Fig. 4D) . Most of the epididymis tubes of the cell treated groups had spermatozoa, but some tubes were empty (Fig. 4C) . Moreover, spermatozoa appeared in the epididymis of the BM-MSCs treated group (Figs. 5E and 5F). In comparison with the treated group, normal intact guinea pigs had more condensed germinal epithelium and all the epididymis tubes were filled with spermatozoa. Histomorphometric findings. Fig. 5 shows the stereological indices of the seminiferous tubules in busulfan-induced azoospermic testis treated with BM-MSCs, in comparison with busulfan-treated testes (positive control) and intact normal testis (negative control) in guinea pigs. There were no significant statistical differences in the luminal diameter and luminal area of the seminiferous tubules of the testes between the busulfan and the BM-MSCs-treated groups (P>0.05), but both groups had larger luminal diameters and areas of seminiferous tubules than the negative control group (P<0.05, Figs. 6A and 6B) . Furthermore, the cellular diameter and area, total diameter and cross-sectional area of seminiferous tubules of the cell treated and negative control groups were larger than in the busulfan azoospermic testes (P<0.05, Figs. 6C, 6D, 6E and 6F). Interestingly, the cellular diameter and area, total diameter and cross-sectional area of seminiferous tubules cell of the treated groups were larger than in the intact testis of the negative control group (P<0.05). On the other hand, the spermatogenesis index of the seminiferous tubules in the negative control and the cell therapy testes was significantly higher than in the busulfantreated control testes (P<0.05, Fig. 6 ). 
Discussion
Our findings showed that BM-MSCs injected into busulfan-induced azoospermia in guinea pigs could induce spermatogenesis. Consistent with our findings, in mice, transplantation of BM-MSCs into the testis of a busulfan-induced infertile mouse model could induce differentiation of these cells into germ, Sertoli and Leydig cells (LUE et al., 2007) . However, in contrast to our findings, it was shown that injection of BM-MSCs into the testis of mice could not induce differentiation into germ cells (LASSALLE et al., 2008) . In another rodent species, hamsters, intra-seminiferous tubule injection of BM-MSCs activated spermatogenesis in a busulfan-induced azoospermic model . Furthermore, intra-seminiferous tubule injection (ZAHKOOK et al., 2014; ZHANG et al., 2014) and intra-testicular injection of BM-MSCs (MONSEFI et al., 2013) were also found to induce spermatogenesis in the seminiferous tubules of busulfan-induced azoospermic rats. Furthermore, the same results with BM-MSCs therapy were found in a testicular torsion model of azoospermia in rats (SABBAGHI et al., 2012) . On the other hand, in rats, treatment of busulfan-induced infertile rats with adipose tissue derived MSCs was also demonstrated to lead to morphologically normal spermatogenesis (CAKICI et al., 2013; MEHRABANI et al., 2015b) . Also, transplantation of human umbilical cord MSCs into seminiferous tubules of immunodeficient mice led to the sperm differentiation of those cells (CHEN et al., 2015) . Our findings, and consideration of other study results, may explain the recovery mechanisms of spermatogenesis after transplantation of MSCs. The first hypothesis is the differentiation of MSCs into the target cells through proper induction conditions (GNECCHI and MELO, 2009 ). The success of in vitro differentiation of BMMSCs into germ cells and spermatozoa was previously reported (DRUSENHEIMER et al., 2007) . The second hypothesis is the secretion of growth factors by MSCs that stimulate the resident spermatogonia to restore the function of the host cells (LEATHERMAN, 2013) . This hypothesis may be supported by consideration of the method of azoospermia induction in the present study, when busulfan had no effects on DNA synthesis, however, when busulfan intoxicated the cells in the G1 phase, it could inhibit the next mitosis stage (DE ROOIJ and VERGOUWEN, 1990) . The last mechanism is the merging of MSCs with endogenous seminiferous tubule cells to recover the injured tissue function (MANSOUR et al., 2012) . Incidentally, without paying attention to the mechanism and MSCs source, all these animal models showed that MSCs therapy can be beneficial to reduce the side effects of chemotherapy on spermatogenesis.
Furthermore, although donor and recipient animals were not syngeneic, and despite the immune-competitive character of the donor guinea pigs, allotransplantation of BMMSCs into the seminiferous tubules of busulfan-induced azoospermic guinea pigs had therapeutic effects. Commenting on this topic, three points may be noticed. The first is the immune privilege character of seminiferous tubules. Certain sites of some tissues in immunocompetent wild type mammalians are immune privileged, including the eye, the brain, the pregnant uterus (NIEDERKORN, 2006) and the testicles (MEINHARDT and HEDGER, 2011) . Sertoli cells were shown to be immune tolerant cells that can facilitate the survival and protection of allogenic transplanted BM-MSCs from any posttransplantation immune or inflammatory reactions (MITAL et al., 2010) . The second point is the pharmacological character of busulfan. Busulfan is a chemotherapeutic agent that is mostly used in low doses and for a long time in the treatment of chronic myeloid leukemia (SUTTORP and MILLOT, 2010) , and before any allogeneic transplantation of hematopoietic cells, it is administered as a myeloablastive agent (BARTELINK et al., 2014) . The last point is related to the BM-MSCs character, which is shown to be not only hypo-immunogenic but also to have immune-surveillance or immunosuppressive properties upon transplantation, and to be a good candidate for allogeneic transplantation (AI et al., 2012) . Interestingly, intravenous transfusion of BM-MSCs was demonstrated to have immunomodulatory effects for the production of antisperm antibodies in allogeneic transplantations in mice after testicular ruptures (AGHAMIR et al., 2014) . Therefore, allotransplantation of MSCs may be considered as the method of choice for azoospermia cell therapy.
The histomorphometric indices of the treated seminiferous tubules in the guinea pigs interestingly showed that cellular diameter and area, as well as total diameter and cross-sectional area were greater after cell therapy than in the control negative group. This phenomenon of an increase in the volume of seminiferous tubules may be caused by the increase in the area of the seminiferous tubules before and after transplantation. Before transplantation, as observed in the increase in the luminal area in the azoospermic group, the decrease in cellular layers may cause a reduction in the resistance of the tubal structure and the collapse of some tubules under the intratubular hydrostatic pressure in the seminiferous tubules. Therefore, the increase in the spaces in the testis may result in an increase in the diameter of the other tubes. Simultaneously, the increase in the diameter of the non-collapsed tube after azoospermia induction and also the increase in the total area of the tubes during this period before treatment may reduce the ability to contract of the contractile myofibroblast cells in the peritubular layer, so altogether these disorders could decrease intratubular hydrostatic pressure. It is necessary to state that although the role of this pressure in the mechanism of spermatogenesis in guinea pig has not yet been clarified, pressure reduction may be one reason for the increase in the diameter of the cellular layer in the AT-MSCs treated tubes. The increase in the cellular area of the seminiferous tubules in the cell therapy group might also be caused by the greater space for Sertoli cells non-affected with busulfan in the germinal layer, which caused the cells to cover a more two-dimensional area than the normal group. On the other hand, the method of cell therapy in the guinea pig model, performed by direct injection of cells into the seminiferous tubules, in comparison with other species, including rats and hamsters which were injected via the ductus efferent (MEHRABANI et al., 2015b; TAMADON et al., 2015; RAHMANIFAR et al., 2016) , may also be another reason for the increase in the diameter of the tubes after cell therapy. The loosened structure of busulfan treated tubules might not be able to resist the pressure of direct injection of cell suspension, and so they dilated. However, the findings of spermatogenesis indices in the cell therapy group showed that the number of cells did not differ between the normal intact tubules and the treated groups, which shows an increase in volume of the cellular layer, although the diameter of cellular layer had increased. However cell therapy could not reverse all the side effects of busulfan treatment and the enlarged inter-Sertoli cell spaces appeared to be filled with a lower number of germinal epithelial cells than expected.
In conclusion, our morphometric findings noted a new feature of cell therapy for azoospermia in a guinea pig azoospermia model that could facilitate the fast repair of pathological changes in testicular seminiferous tubules. BM-MSCs were effective in treatment of azoospermia in the guinea pig model, and restored the fertility of busulfan induced azoospermic animals after transplantation of BM-MSCs. These results could open a window in the future to the possibility of BM-MSCs transplantation in the treatment of azoospermia in humans, but more studies should be undertaken to verify this issue. 
